In agreement with previous studies, we showed that FBXO45 functions as a tumor suppressor, particularly for more aggressive breast cancer subtypes, indicating that the anti-metastatic effects of FBXO45 are strikingly cancer-type specific. The gene discussed is FBXO45; the disease is neoplasm.